The HSPA4 Knockout Jurkat Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the human Jurkat T lymphoblast cell line. This product provides a loss-of-function model for the HSPA4 gene, enabling investigation of its biological roles without introducing specific mutation patterns. The polyclonal nature ensures diverse genetic edits across the population, suitable for pooled studies of gene disruption effects. By targeting HSPA4, researchers can dissect its contributions to protein homeostasis and apoptotic signaling networks in a well-characterized immortalized T lymphocyte background.
Jurkat cells are an extensively utilized T lymphoblast line originally isolated from the peripheral blood of a 14-year-old male with acute T cell leukemia. These cells exhibit robust proliferation and have been foundational in studies of T cell receptor signaling, cytokine production, and programmed cell death. Their genetic tractability and well-documented signaling pathways make them an ideal host for CRISPR-based gene editing, particularly for examining molecular chaperone functions in a leukemia-relevant context. The parental Jurkat line retains many features of T cell biology, allowing physiologically meaningful interpretations of knockout phenotypes.
HSPA4 encodes a stress-inducible molecular chaperone that facilitates protein folding, targets misfolded proteins for degradation, and critically represses apoptosis. Transcriptionally activated by heat shock factor 1 (HSF1) and E2F1, HSPA4 protein activity is further modulated by Akt kinase. The chaperone cooperates with co-factors BAG family members, CHIP/STUB1, and HOP to regulate client protein maturation. Downstream, HSPA4 promotes cell survival by stabilizing anti-apoptotic Bcl-2 and inhibiting caspase-3 cleavage, operating through a characterized HSPA4 ?? AKT ?? BAD ?? Caspase-9 signaling axis. These interactions position HSPA4 at a central node connecting proteotoxic stress responses to cell fate decisions.
Knockout of HSPA4 in Jurkat cells is predicted to compromise chaperone-mediated protein folding capacity and ablate the anti-apoptotic signaling conveyed through Akt and Bcl-2. The resulting model is expected to exhibit heightened sensitivity to endoplasmic reticulum stress, oxidative injury, and other insults that trigger intrinsic apoptosis. This sensitization offers a defined experimental system to probe how protein quality control failure amplifies caspase activation in T lymphoblasts, with direct implications for understanding leukemia cell vulnerabilities and the molecular basis of resistance to therapeutic agents.
This polyclonal knockout cell product is well-suited for a diverse array of research applications. Investigators can perform Western blotting to assess HSPA4, Bcl-2, and cleaved caspase-3 levels, flow cytometry to quantify apoptosis using Annexin V and propidium iodide staining, RT-qPCR to profile HSP70 family member expression, and co-immunoprecipitation to map HSPA4 interactions with BAG proteins. Such assays enable detailed mechanistic dissection of protein homeostasis, stress responses, and apoptosis regulation, supporting cancer cell survival studies, drug target validation, and pathway analysis of MAPK signaling. For additional details or technical inquiries, please contact Ascent Research.
